Literature DB >> 17725607

Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice.

Maroof Hasan1, Gabriela Lopez-Herrera, K Emelie M Blomberg, Jessica M Lindvall, Anna Berglöf, C I Edvard Smith, Leonardo Vargas.   

Abstract

Bruton's tyrosine kinase (Btk), a member of the Tec family of tyrosine kinases, plays an important role in the differentiation and activation of B cells. Mutations affecting Btk cause immunodeficiency in both humans and mice. In this study we set out to investigate the potential role of Btk in Toll-like receptor 9 (TLR9) activation and the production of pro-inflammatory cytokines such as interleukin (IL)-6, tumour necrosis factor (TNF)-alpha and IL-12p40. Our data show that Btk-deficient B cells respond more efficiently to CpG-DNA stimulation, producing significantly higher levels of pro-inflammatory cytokines but lower levels of the inhibitory cytokine IL-10. The quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis presented in this work shows that mRNA production of one of the important new members of the IL-12 family, IL-27, was significantly increased in Btk-deficient B cells after CpG-DNA stimulation. In this study, we demonstrate significant differences in CpG responsiveness between transitional 1 (T1) and T2 B cells for survival and maturation. Furthermore, TLR9 expression, measured both as protein and as mRNA, was increased in Btk-defective cells, especially after TLR9 stimulation. Collectively, these data provide evidence in support of the theory that Btk regulates both TLR9 activation and expression in mouse splenic B cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17725607      PMCID: PMC2433303          DOI: 10.1111/j.1365-2567.2007.02693.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  58 in total

1.  Mechanism and function of a newly identified CpG DNA motif in human primary B cells.

Authors:  G Hartmann; A M Krieg
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

Review 2.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 3.  Mammalian Toll-like receptors.

Authors:  Shizuo Akira
Journal:  Curr Opin Immunol       Date:  2003-02       Impact factor: 7.486

4.  Requirement for Tec kinases in chemokine-induced migration and activation of Cdc42 and Rac.

Authors:  Aya Takesono; Reiko Horai; Michiko Mandai; Derek Dombroski; Pamela L Schwartzberg
Journal:  Curr Biol       Date:  2004-05-25       Impact factor: 10.834

Review 5.  Inferences, questions and possibilities in Toll-like receptor signalling.

Authors:  Bruce Beutler
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

6.  Functional interaction of caveolin-1 with Bruton's tyrosine kinase and Bmx.

Authors:  Leonardo Vargas; Beston F Nore; Anna Berglof; Juhana E Heinonen; Pekka T Mattsson; C I Edvard Smith; Abdalla J Mohamed
Journal:  J Biol Chem       Date:  2001-12-19       Impact factor: 5.157

7.  Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.

Authors:  G Hartmann; R D Weeratna; Z K Ballas; P Payette; S Blackwell; I Suparto; W L Rasmussen; M Waldschmidt; D Sajuthi; R H Purcell; H L Davis; A M Krieg
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

8.  Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.

Authors:  Veit Hornung; Simon Rothenfusser; Stefanie Britsch; Anne Krug; Bernd Jahrsdörfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

9.  Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help.

Authors:  Hendrik Poeck; Moritz Wagner; Julia Battiany; Simon Rothenfusser; Daniela Wellisch; Veit Hornung; Bernd Jahrsdorfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  Blood       Date:  2003-12-30       Impact factor: 22.113

10.  Gene expression profile of B cells from Xid mice and Btk knockout mice.

Authors:  Jessica M Lindvall; K Emelie M Blomberg; Anna Berglöf; Qian Yang; C I Edvard Smith; Tahmina C Islam
Journal:  Eur J Immunol       Date:  2004-07       Impact factor: 5.532

View more
  20 in total

1.  Increased pro-inflammatory cytokine production after lipopolysaccharide stimulation in patients with X-linked agammaglobulinemia.

Authors:  María Edith González-Serrano; Iris Estrada-García; Dolores Mogica-Martínez; Alejandro González-Garay; Gabriela López-Herrera; Laura Berrón-Ruiz; Sara Elva Espinosa-Padilla; Marco Antonio Yamazaki-Nakashimada; Alexander Vargas-Hernández; Leopoldo Santos-Argumedo; Sergio Antonio Estrada-Parra; Francisco J Espinosa-Rosales
Journal:  J Clin Immunol       Date:  2012-06-05       Impact factor: 8.317

Review 2.  Toll-like receptors--sentries in the B-cell response.

Authors:  Isabelle Bekeredjian-Ding; Gaetan Jego
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

Review 3.  TLR signaling in B-cell development and activation.

Authors:  Zhaolin Hua; Baidong Hou
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

4.  Cross-Reactive Antigen Expressed by B6 Splenocytes Drives Receptor Editing and Marginal Zone Differentiation of IgG2a-Reactive AM14 Vκ8 B Cells.

Authors:  Kerstin Nündel; Purvi Mande; Stephanie L Moses; Patricia Busto; Jaime L Cullen; Madelyn R Schmidt; Mark J Shlomchik; Robert T Woodland; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2019-09-18       Impact factor: 5.422

5.  Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus.

Authors:  Vincent Gies; Jean-Nicolas Schickel; Sophie Jung; Aurélie Joublin; Salomé Glauzy; Anne-Marie Knapp; Anne Soley; Vincent Poindron; Aurélien Guffroy; Jin-Young Choi; Jacques-Eric Gottenberg; Jennifer H Anolik; Thierry Martin; Pauline Soulas-Sprauel; Eric Meffre; Anne-Sophie Korganow
Journal:  JCI Insight       Date:  2018-03-08

6.  Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines.

Authors:  Thomas U Marron; Monica Martinez-Gallo; Joyce E Yu; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2011-11-16       Impact factor: 10.793

7.  TLR signaling and effector functions are intact in XLA neutrophils.

Authors:  Thomas U Marron; Kaileen Rohr; Monica Martinez-Gallo; Joyce Yu; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2010-07-14       Impact factor: 3.969

8.  The Toll-like receptor 9 signalling pathway regulates MR1-mediated bacterial antigen presentation in B cells.

Authors:  Jianyun Liu; Randy R Brutkiewicz
Journal:  Immunology       Date:  2017-06-29       Impact factor: 7.397

9.  Bruton's tyrosine kinase: from X-linked agammaglobulinemia toward targeted therapy for B-cell malignancies.

Authors:  Sabine Ponader; Jan A Burger
Journal:  J Clin Oncol       Date:  2014-04-28       Impact factor: 44.544

10.  Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.

Authors:  Kristina E Halcomb; Sandirai Musuka; Toni Gutierrez; Heather L Wright; Anne B Satterthwaite
Journal:  Mol Immunol       Date:  2008-10-11       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.